Ascendis' (ASND) TransCon hGH Gets EU Nod for Pediatric GHD

Published on January 14, 2022

Ascendis Pharma (ASND) gets nod in Europe for TransCon hGH for the treatment of pediatric growth hormone deficiency.

Continue reading on website
Other news

4 Top Penny Stocks To Watch For A Short Squeeze

January 14, 2022
Short squeeze penny stocks to watch

Equinor (EQNR) Revises Mariner Oilfield Reserves in UK North Sea

January 14, 2022
Equinor (EQNR) plans to continue drilling on the field to increase cash flow in the future.